document.write("
"); document.write("
Scholz,\ S.*\ ; Koerber,\ F.\ ; Meszaros,\ K.*\ ; Fassbender,\ R.M.*\ ; Ultsch,\ B.*\ ; Welte,\ R.R.*\ ; Greiner,\ W.*
"); document.write("
The cost-of-illness for invasive meningococcal disease caused by serogroup B Neisseria meningitidis (MenB) in Germany.
"); document.write("
Vaccine 37, 1692-1701 (2019)
"); document.write("
"); document.write("
"); document.write("
Ghasemi,\ A.*\ ; Mohammad,\ N.*\ ; Mautner,\ J.\ ; Taghipour Karsabet,\ M.*\ ; Amani,\ J.*\ ; Ardjmand,\ A.*\ ; Vakili,\ Z.*
"); document.write("
Immunization with a recombinant fusion protein protects mice against Helicobacter pylori infection.
"); document.write("
Vaccine 36, 5124-5132 (2018)
"); document.write("
"); document.write("
"); document.write("
Beyerlein,\ A.\ ; Strobl,\ A.N.*\ ; Winkler,\ C.\ ; Carpus,\ M.\ ; Knopff,\ A.\ ; Donnachie,\ E.*\ ; Ankerst,\ D.P.*\ ; Ziegler,\ A.-G.
"); document.write("
Vaccinations in early life are not associated with development of islet autoimmunity in type 1 diabetes high-risk children: Results from prospective cohort data.
"); document.write("
Vaccine 35, 1735-1741 (2017)
"); document.write("
"); document.write("
"); document.write("
Link,\ E.K.*\ ; Brandmüller,\ C.*\ ; Suezer,\ Y.*\ ; Ameres,\ S.\ ; Volz,\ A.*\ ; Moosmann,\ A.\ ; Sutter,\ G.*\ ; Lehmann,\ M.H.*
"); document.write("
A synthetic human cytomegalovirus pp65-IE1 fusion antigen efficiently induces and expands virus specific T cells.
"); document.write("
Vaccine 35, 5131-5139 (2017)
"); document.write("
"); document.write("
"); document.write("
Backes,\ S.\ ; Jager,\ C.\ ; Dembek,\ C.J.\ ; Kosinska,\ A.\ ; Bauer,\ T.\ ; Stephan,\ A.-S.\ ; Dišlers,\ A.*\ ; Mutwiri,\ G.*\ ; Busch,\ D.H.\ ; Babiuk,\ L.A.*\ ; Gasteiger,\ G.\ ; Protzer,\ U.
"); document.write("
Protein-prime/modified vaccinia virus Ankara vector-boost vaccination overcomes tolerance in high-antigenemic HBV-transgenic mice.
"); document.write("
Vaccine 34, 923-932 (2016)
"); document.write("
"); document.write("
"); document.write("
Ghasemi,\ A.*\ ; Jeddi-Tehrani,\ M.*\ ; Mautner,\ J.\ ; Salari,\ M.H.*\ ; Zarnani,\ A.H.*
"); document.write("
Simultaneous immunization of mice with Omp31 and TF provides protection against \Brucella melitensis\ infection.
"); document.write("
Vaccine 33, 5532-5538 (2015)
"); document.write("
"); document.write("
"); document.write("
Ghasemi,\ A.*\ ; Jeddi-Tehrani,\ M.*\ ; Mautner,\ J.\ ; Salari,\ M.H.*\ ; Zarnani,\ A.H.*
"); document.write("
Immunization of mice with a novel recombinant molecular chaperon confers protection against \Brucella melitensis\ infection.
"); document.write("
Vaccine 32, 6659-6666 (2014)
"); document.write("
"); document.write("
"); document.write("
von Sonnenburg,\ F.*\ ; Perona,\ P.*\ ; Darsow,\ U.\ ; Ring,\ J.\ ; von Krempelhuber,\ A.*\ ; Vollmar,\ J.*\ ; Roesch,\ S.*\ ; Baedeker,\ N.*\ ; Kollaritsch,\ H.*\ ; Chaplin,\ P.*
"); document.write("
Safety and immunogenicity of modified vaccinia Ankara as a smallpox vaccine in people with atopic dermatitis.
"); document.write("
Vaccine 32, 5696-5702 (2014)
"); document.write("
"); document.write("
"); document.write("
Buchmann,\ P.*\ ; Dembek,\ C.J.\ ; Kuklick,\ L.*\ ; Jager,\ C.*\ ; Tedjokusumo,\ R.\ ; von Freyend,\ M.J.*\ ; Drebber,\ U.*\ ; Janowicz,\ Z.*\ ; Melber,\ K.*\ ; Protzer,\ U.
"); document.write("
A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in Hepatitis B Virus (HBV) transgenic mice.
"); document.write("
Vaccine 31, 1197-1203 (2013)
"); document.write("
"); document.write("
"); document.write("
Braeckman,\ T.*\ ; van Herck,\ K.*\ ; Jilg,\ W.*\ ; Bauer,\ T.*\ ; van Damme,\ P.*
"); document.write("
Two decades of hepatitis B vaccination in mentally retarded patients: effectiveness, antibody persistence and duration of immune memory.
"); document.write("
Vaccine 30, 4757-4761 (2012)
"); document.write("
"); document.write("
"); document.write("
Farag,\ M.M.S.*\ ; Tedjokusumo,\ R.\ ; Flechtenmacher,\ C.*\ ; Asen,\ T.\ ; Stremmel,\ W.*\ ; Müller,\ M.*\ ; Protzer,\ U.\ ; Weigand,\ K.*
"); document.write("
Immune tolerance against HBV can be overcome in HBV transgenic mice by immunization with dendritic cells pulsed by HBVsvp.
"); document.write("
Vaccine 30, 6034-6039 (2012)
"); document.write("
"); document.write("
"); document.write("
Schlosser,\ E.*\ ; Mueller,\ M.*\ ; Fischer,\ S.*\ ; Basta,\ S.*\ ; Busch,\ D.H.\ ; Gander,\ B.*\ ; Groettrup,\ M.*
"); document.write("
TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses.
"); document.write("
Vaccine 26, 1626-1637 (2008)
"); document.write("
"); document.write("
"); document.write("
Schulze,\ K.*\ ; Staib,\ C.\ ; Schatzl,\ H.M.*\ ; Ebensen,\ T.*\ ; Erfle,\ V.\ ; Guzman,\ C.A.*
"); document.write("
A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirus.
"); document.write("
Vaccine 26, 6678-6684 (2008)
"); document.write("
"); document.write("
"); document.write("
Antonis,\ A.F.G.*\ ; van der Most,\ R.G.*\ ; Suezer,\ Y.*\ ; Stockhofe-Zurwieden,\ N.*\ ; Daus,\ F.*\ ; Sutter,\ G.\ ; Schrijver,\ R.S.*
"); document.write("
Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge.
"); document.write("
Vaccine 25, 4818-4827 (2007)
"); document.write("
"); document.write("
"); document.write("
El-Gogo,\ S.*\ ; Staib,\ C.*\ ; Meyr,\ M.*\ ; Erfle,\ V.\ ; Sutter,\ G.\ ; Adler,\ H.
"); document.write("
Recombinant murine gammaherpesvirus 68 (MHV-68) as challenge virus to test efficacy of vaccination against chronic virus infections in the mouse model.
"); document.write("
Vaccine 25, 3934-3945 (2007)
"); document.write("
"); document.write("
"); document.write("
Hahn,\ U.K.*\ ; Aichler,\ M.*\ ; Boehm,\ R.*\ ; Beyer,\ W.*
"); document.write("
Comparison of the immunological memory after DNA vaccination and protein vaccination against anthrax in sheep.
"); document.write("
Vaccine 24, 4595-4597 (2006)
"); document.write("
"); document.write("
"); document.write("
Meyer,\ P.\ ; Menzel,\ M.\ ; Muellinger,\ B.*\ ; Weber,\ N.\ ; Haeussinger,\ K.\ ; Ziegler-Heitbrock,\ L.
"); document.write("
Inhalative vaccination with pneumococcal polysaccharide in patients with chronic obstructive pulmonary disease.
"); document.write("
Vaccine 24, 5832-5838 (2006)
"); document.write("
"); document.write("
"); document.write("
Menzel,\ M.*\ ; Muellinger,\ B.*\ ; Weber,\ N.\ ; Häussinger,\ K.\ ; Ziegler-Heitbrock,\ L.
"); document.write("
Inhalative vaccination with pneumococcal polysaccharide in healthy volunteers.
"); document.write("
Vaccine 23, 5113-5119 (2005)
"); document.write("
"); document.write("
"); document.write("
Olszewska,\ W.*\ ; Suezer,\ Y.\ ; Openshaw,\ P.J.M.*
"); document.write("
Protective and disease-enhancing immune responses induced by recombinant modified vaccinia Ankara (MVA) expressing respiratory syncytial virus proteins.
"); document.write("
Vaccine 23, 215-221 (2004)
"); document.write("
"); document.write("
"); document.write("
Welte,\ R.\ ; van den Dobbelsteen,\ G.*\ ; Bos,\ J.M.*\ ; de Melker,\ H.*\ ; van Alphen,\ L.*\ ; Spanjaard,\ L.*\ ; Rümke,\ H.C.*\ ; Postma,\ M.J.*
"); document.write("
Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-making.
"); document.write("
Vaccine 23, 470-479 (2004)
"); document.write("
"); document.write("
"); document.write("
Cosma,\ A.\ ; Nagaraj,\ R.\ ; Bühler,\ S.*\ ; Hinkula,\ J.*\ ; Busch,\ D.H.*\ ; Sutter,\ G.\ ; Goebel,\ F.D.*\ ; Erfle,\ V.
"); document.write("
Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals.
"); document.write("
Vaccine 22, 21-29 (2003)
"); document.write("
"); document.write("
"); document.write("
Stittelaar,\ K.J.*\ ; Gruters,\ R.A.*\ ; Schutten,\ M.*\ ; van Baalen,\ C.A.*\ ; van Amerongen,\ G.*\ ; Cranage,\ M.*\ ; Liljeström,\ P.*\ ; Sutter,\ G.\ ; Osterhaus,\ A.D.M.E.*
"); document.write("
Comparison of the efficacy of early versus late viral proteins in vaccination against SIV.
"); document.write("
Vaccine 20, 2921-2927 (2002)
"); document.write("
"); document.write("
"); document.write("
Nilsson,\ C.*\ ; Mäkitalo,\ B.*\ ; Berglund,\ P.*\ ; Bex,\ F.*\ ; Liljeström,\ P.*\ ; Sutter,\ G.\ ; Erfle,\ V.\ ; Ten Haaft,\ P.*\ ; Heeney,\ J.*\ ; Biberfeld,\ G.*\ ; Thorstensson,\ R.*
"); document.write("
Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus Ankara.
"); document.write("
Vaccine 19, 3526-3536 (2001)
"); document.write("
"); document.write("
"); document.write("
Collings,\ A.*\ ; Pitkänen,\ J.*\ ; Strengell,\ M.*\ ; Tähtinen,\ M.*\ ; Lagerstedt,\ A.*\ ; Hakkarainen,\ K.*\ ; Ovod,\ V.*\ ; Sutter,\ G.\ ; Ustav,\ M.*\ ; Ustav,\ E.*\ ; Männik,\ A.*
"); document.write("
Humoral and cellular immune responses to HIV-1 Nev in mice DNA-immunised with non- replicating or self-replicating expression vectors.
"); document.write("
Vaccine 18, 460-467 (2000)
"); document.write("
"); document.write("
"); document.write("
Osterhaus,\ A.D.*\ ; van Baalen,\ C.A.*\ ; Gruters,\ R.A.*\ ; Schutten,\ M.*\ ; Siebelink,\ C.H.J.*\ ; Hulskotte,\ E.G.J.*\ ; Tijhaar,\ E.J.*\ ; Randall,\ R.E.R.*\ ; van Amerongen,\ G.*\ ; Fleuchaus,\ A.G.\ ; Erfle,\ V.\ ; Sutter,\ G.
"); document.write("
Vaccination with Rev and Tat against AIDS.
"); document.write("
Vaccine 17, 2713-2714 (1999)
"); document.write("
"); document.write("
"); document.write("
von Brunn,\ A. \ ; Reichhuber,\ C.\ ; Brand,\ M.\ ; Bechowsky,\ B.\ ; Gürtler,\ L.\ ; Eberle,\ J.\ ; Kleinschmidt,\ A.\ ; Erfle,\ V.\ ; Schödel,\ F.
"); document.write("
The Principal Neutralizing Determinant (V3) of HIV-1 Induces HIV-1-neutralizing Antibodies upon Expression on HBcAg Particles.
"); document.write("
Vaccine 93 (1993)
"); document.write("
");